90833462 - ESGPHARM

Information

  • Trademark
  • 90833462
  • Serial Number
    90833462
  • Filing Date
    July 16, 2021
    3 years ago
  • Transaction Date
    March 21, 2023
    a year ago
  • Status Date
    March 21, 2023
    a year ago
  • Location Date
    March 21, 2023
    a year ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    VERHOSEK, WILLIAM T
  • Attorney Docket Number
    520113
    Attorney Name
    Diane J. Mason
    Law Office Assigned Location Code
    M50
  • Owners
Mark Drawing Code
4000
Mark Identification
ESGPHARM
Case File Statements
  • GS0401: Custom manufacture of pharmaceuticals; custom manufacturing services in the nature of processing of pharmaceutical preparations; custom manufacturing services in the nature of processing of medicinal materials; custom manufacture of biopharmaceuticals; treatment of biopharmaceutical materials; processing of biopharmaceutical materials for others; custom manufacturing services in the nature of processing of biopharmaceutical materials for others; preservation of pharmaceuticals; custom manufacturing services in the nature of processing of medical products; processing of plant material; processing of plant extracts in the nature of separation of extractants; processing of plants to obtain oils from plant material; processing of biomass; prototype fabrication of new products for others; custom manufacturing services in the nature of processing of plant growth promoting preparations; conversion of targeted substrates into targeted chemical preparations by treatment with enzyme systems; custom manufacture of pharmaceuticals using biological organisms in the manufacturing process; custom manufacturing services in the nature of processing of pharmaceutical preparations using biological organisms; custom manufacture of machines and tools for compressing and compacting powders and granules
  • GS0441: Consultancy and information services relating to pharmaceutical products; advisory services relating to pharmaceutical products; medical consultancy relating to pharmaceutical and medical products; advisory services relating to pharmaceuticals; providing consultancy and information services relating to biopharmaceutical products; pharmaceutical advice; consultancy and information services provided via the Internet relating to pharmaceutical products; cultivation of plants for use in pharmaceuticals for others; farming services in the field of plants used for pharmaceuticals; cultivation of host plants for plant-based biopharmaceutical production for others; plant seed services, namely, providing data, information and analysis in the field of seed performance for medical purposes; information services relating to flora used in pharmaceuticals and medical treatments; plant nursery services; cultivation of plants for use in the development of biopharmaceuticals for others; provision of gene therapy for medical treatment purposes; provision of genetic information for medical treatment purposes; analysis of human biodata for medical purposes; DNA analysis for medical purposes; genetic testing for medical purposes
  • GS0421: Pharmaceutical research and development; pharmaceutical drug development services; inspection of pharmaceuticals; consultancy in the fields of pharmaceutical research and development; analysis and evaluation of medical product development; research relating to medicines; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; research and development in the field of plant-based biopharmaceutical production; development of pharmaceutical preparations and medicines; medical research in the field of crude drugs; microbial culture trials; protein analysis for scientific research purposes; industrial analysis and research services in the field of protein analysis; genetic engineering services relating to plants; scientific research relating to genetics of plants; providing laboratory research services in the field of gene expression, namely, cancer biology; laboratory services relating to the production of monoclonal antibodies; genetic engineering services relating to plants for pharmaceuticals; scientific research relating to plant breeding for pharmaceuticals
Case File Event Statements
  • 3/21/2023 - a year ago
    10 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 3/21/2023 - a year ago
    9 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 3/21/2023 - a year ago
    8 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 3/20/2023 - a year ago
    7 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/14/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/14/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/14/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/6/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/20/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/20/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP